Evidence map›Paper›PMID 30419792›Full record

ArticlePulmonary circulation

Validation of a claims-based algorithm to identify patients with chronic thromboembolic pulmonary hypertension using electronic health record data.

Simon Teal, William R Auger, Rodney J Hughes, Dena Rosen Ramey, Kelly S Lewis, Gerald O'Brien, Avin Yaldo, Tanya M Burton, Tim Bancroft, Jerry Seare and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pulmonary circulation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Simon Teal1 Bayer AG, Berlin, Germany.
William R Auger2 University of California, San Diego, LA Jolla, CA, USA.
Rodney J Hughes3 Sheffield Teaching Hospitals, Sheffield, UK.
Dena Rosen Ramey4 Merck & Co, Inc, Kenilworth, NJ, USA.
Kelly S Lewis5 Bayer Healthcare Pharmaceuticals, Whippany, NJ, USA.
Gerald O'Brien5 Bayer Healthcare Pharmaceuticals, Whippany, NJ, USA.
Avin Yaldo5 Bayer Healthcare Pharmaceuticals, Whippany, NJ, USA.
Tanya M Burton6 Optum, Eden Prairie, MN, USA.
Tim Bancroft6 Optum, Eden Prairie, MN, USA.
Jerry Seare6 Optum, Eden Prairie, MN, USA.
Joerg Fabian7 Bayer Business Services GmbH, Leverkusen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to validate an algorithm developed to identify chronic thromboembolic pulmonary hypertension (CTEPH) among patients with a history of pulmonary embolism. Validation was halted because too few patients had gold-standard evidence of CTEPH in the administrative claims/electronic health records database, suggesting that CTEPH is underdiagnosed.

Indexed as

administrative claimsdatabasesearly diagnosisfactualhealthcare

Identifiers

PMID30419792
PMCPMC6287311

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.